MNOV
MediciNova Inc
2.90$
-12.1%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +39.0% | +5.0% | +9.1% | +77.9% | +2.6% | -4.8% | +15.9% | -15.2% | -10.6% | -15.7% | -18.4% | |
| – | +87.3% | +8.7% | +14.7% | +121.5% | +2.5% | -5.6% | +18.6% | -18.1% | -13.2% | -19.7% | -24.5% | |
| – | +89.2% | +9.2% | +16.1% | +122.6% | +2.4% | -5.9% | +19.0% | -74.1% | +175.6% | -20.9% | -23.7% | |
| – | +89.2% | +9.2% | +16.1% | +122.6% | +2.4% | -5.9% | +19.0% | -18.1% | -12.8% | -20.9% | -23.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -54.4% | +344.0% | -30.7% | -15.5% | -23.7% | +37.4% | +3.3% | -21.4% | – | – | – | |
| – | 0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -2.1% | +2.5% | -9.5% | -13.9% | +4.8% | -5.1% | -8.9% | +4.9% | -0.5% | -13.3% | +19.1% | |
| – | -6.5% | +9.4% | +76.7% | -23.9% | +1.7% | -1.5% | +29.1% | +12.5% | +2.9% | -9.8% | +28.3% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -100.0% | +19.4% | +37.1% | -10.3% | +0.3% | |
| – | -63.0% | +115.0% | +313.9% | -59.4% | -26.8% | +36.6% | -34.7% | +5.4% | +136.4% | +9.8% | -43.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +48.8% | +5.4% | +11.9% | +89.2% | +2.4% | -4.8% | +17.3% | -16.1% | -11.2% | -15.8% | -20.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +10.4% | +24.1% | +6.5% | +17.0% | +4.9% | +2.9% | +9.4% | +0.9% | +0.0% | +0.0% | +0.0% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.